Description: The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (?index?). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
Exchange: BATS
Country: US
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 80.26 | 0.00 | 80.26 |
| Stock non-US | 19.74 | 0.00 | 19.74 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 79.59 | 99.57 |
| Basic Materials | 15.30 | 0.10 |
| Consumer Defensive | 5.12 | 0.08 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 80.96 | 92.60 |
| Europe Developed | 11.32 | 4.28 |
| United Kingdom | 4.02 | 1.65 |
| Japan | 2.49 | 0.54 |
| Australasia | 1.21 | 0.11 |
| Asia Emerging | 0.00 | 0.82 |
| Africa/Middle East | 0.00 | 0.02 |